Reuters logo
BRIEF-Monster digital, Innovate Biopharmaceuticals enter into letter of intent regarding reverse merger
June 19, 2017 / 11:16 AM / 6 months ago

BRIEF-Monster digital, Innovate Biopharmaceuticals enter into letter of intent regarding reverse merger

June 19 (Reuters) - Monster Digital Inc

* Monster Digital and Innovate Biopharmaceuticals enter into letter of intent regarding reverse merger

* Monster Digital - LOI contemplates execution of deal whereby security holders of innovate would receive Monster Digital Securities in merger

* Monster Digital - security holders of innovate would receive monster Digital securities in merger, in exchange for securities held in innovate

* Monster Digital - following closing of merger, innovate would become a wholly owned unit of monster digital, monster digital, as surviving company

* Monster Digital - assuming monster digital innovate enter deal,parties to look to seek shareholder approval from Monster Digital’s stockholders in q3 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below